CV Sciences (CVSI) Net Equity Issued and Repurchased (2011 - 2021)

CV Sciences (CVSI) reported Net Equity Issued and Repurchased of $195000.0 for Q4 2021, up 1.04% on a YoY basis from $193000.0 in Q4 2020, and down 45.68% sequentially from $359000.0 in Q3 2021.

CV Sciences (CVSI) Net Equity Issued and Repurchased (2011 - 2021) Analysis & Trends

CV Sciences (CVSI) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $195000.0 in Q4 2021.

  • For the quarter ending Q4 2021, Net Equity Issued and Repurchased rose 1.04% year-over-year to $195000.0; the trailing twelve-month figure through Sep 2022 stood at $195000.0 (down 95.57% YoY), and the FY2021 full-year result was $4.4 million, up 2183.42% from the prior year.
  • Net Equity Issued and Repurchased slipped to $195000.0 in Q4 2021, from $359000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $3.2 million in Q1 2021 to a low of $193000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 195,000.00
Dec 31, 2021 195,000.00
Sep 30, 2021 359,000.00
Sep 30, 2021 359,000.00
Jun 30, 2021 631,000.00
Jun 30, 2021 631,000.00
Mar 31, 2021 3.22 Mn
Mar 31, 2021 3.22 Mn
Dec 31, 2020 193,000.00
Dec 31, 2020 193,000.00
Mar 31, 2015 2.52 Mn
Mar 31, 2015 2.52 Mn
Jun 30, 2014 1.17 Mn
Jun 30, 2014 1.17 Mn
Mar 31, 2014 7.08 Mn
Mar 31, 2014 7.08 Mn
Dec 31, 2013 2.73 Mn
Dec 31, 2013 2.73 Mn
Dec 31, 2011 60,000.00
Dec 31, 2011 60,000.00